Chemo Pharma Laboratories Ltd

BSE : Chemo-Pharma-Laboratories-Ltd24 Jan 2025

Pharmaceuticals

₹

-1.90 (-2.08%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Chemo Pharma Laboratories Ltd

Chemo Pharma Laboratories Ltd

Pharmaceuticals

BSE : Chemo-Pharma-Laboratories-Ltd24 Jan 2025

₹

-1.90 (-2.08%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
13-Jan-2025	BC	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve the following businesses:- 1. To	27-Jan-2025
31-Dec-2024	BC	Intimation for Appointment of Independent Director (Non-Executive) on the Board of Directors of the Company under Regulation 30 of SEBI (LODR) Regulations, 2015.	31-Dec-2024
15-Oct-2024	BC	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the Un-Audited Financial Stateme	28-Oct-2024
29-Jul-2024	BC	1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2024 along with the Limited Review Report thereon. 2. Approval of the Notice of the 82nd Annual General Meeti	23-Sep-2024
29-Jul-2024	BC	Annual General Meeting	17-Sep-2024

No Rights has been declared by Chemo-Pharma-Laboratories-Ltd

Book Closure

Record Date	Split Date	Purpose
27-Jan-2025	-	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve the following businesses:- 1. To
31-Dec-2024	-	Intimation for Appointment of Independent Director (Non-Executive) on the Board of Directors of the Company under Regulation 30 of SEBI (LODR) Regulations, 2015.
28-Oct-2024	-	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the Un-Audited Financial Stateme
23-Sep-2024	-	1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2024 along with the Limited Review Report thereon. 2. Approval of the Notice of the 82nd Annual General Meeti
17-Sep-2024	01 Jan'1900	Annual General Meeting

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Chemo Pharma Laboratories Ltd ₹89.50(-1.90/-2.08%)	89.50	-1.90	13.43	16.99	10.81	0.98
Bliss GVS Pharma Ltd ₹161.95(-2.65/-1.61%)	161.95	-2.65	1,706.41	40.64	21.11	1.67
Amrutanjan Health Care Ltd ₹693.15(-6.55/-0.94%)	693.15	-6.55	2,003.94	17.49	42.16	6.73
Astrazeneca Pharma India Ltd ₹6,929.95(-143.25/-2.03%)	6,929.95	-143.25	17,324.88	8.17	134.59	25.50
Abbott India Ltd ₹27,272.70(-565.65/-2.03%)	27,272.70	-565.65	57,954.49	6.52	45.11	16.46
Ambalal Sarabhai Enterprises Ltd ₹49.26(-0.56/-1.12%)	49.26	-0.56	377.50	0.55	42.83	8.38

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	0.56	0.69	2.17	0.81	2.97
Net Cash from Operating Activities	0.72	-0.68	-0.33	-0.41	4.83
Net Cash Used In Investing Activities	-0.52	0.63	0.97	-0.19	1.01
Net Cash Used In Financing Activities	-0.15	-0.08	-2.12	1.96	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.05	-0.13	-1.49	1.36	5.84
Cash And Cash Equivalents At End Of The Year	0.61	0.56	0.69	2.17	8.81

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

27.89%

FII Shareholding

0.00%

DII Shareholding

0.37%

Public Shareholding

71.75%

**Promoter pledged shareholding 27.89%

About Chemo Pharma Laboratories Ltd

Chemo Pharma Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 13.43 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0.61 crores for the quarter ended December 2018. The company management includes , Ashok Somani,Toby Antony,Shanta Somani,Mathura Prasad Sharma,Bhavin Sheth,Nandkumar Pareek,Unnatti Jain (Chemo Pharma Laboratories Ltd) among others.

Chairman

Registered office

5 Kumud Apartment CHS Ltd,Karnik Road Chikan Ghar Kalyan,Thane,Maharashtra,421301

FAX :

Background

Incorporation Year1942

Face Value₹10

Market Lot1